Primary progressive aphasia

From WikiMD's WELLNESSPEDIA

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Primary progressive aphasia
Diagram showing areas of the brain affected by aphasia
Synonyms N/A
Pronounce N/A
Specialty N/A
Symptoms Language difficulties, speech production issues, comprehension problems
Complications N/A
Onset Typically between ages 50 and 70
Duration Progressive
Types Nonfluent variant PPA, Semantic variant PPA, Logopenic variant PPA
Causes Neurodegenerative disease
Risks Genetic predisposition, age
Diagnosis Clinical assessment, neuroimaging, neuropsychological testing
Differential diagnosis Alzheimer's disease, Frontotemporal dementia, Stroke
Prevention N/A
Treatment Speech therapy, occupational therapy, supportive care
Medication N/A
Prognosis Progressive decline in language abilities
Frequency Rare
Deaths N/A


Primary progressive aphasia (PPA) is a type of neurodegenerative disorder that primarily affects language skills and communication. It is characterized by a gradual and progressive loss of language function, while other cognitive abilities may remain relatively preserved for at least 2 years after the onset of language symptoms.

Symptoms[edit]

The symptoms of PPA can vary depending on the specific type of aphasia. However, common symptoms include difficulty with speech, reading, writing, and understanding language. These difficulties can affect a person's ability to communicate effectively and can lead to frustration and social isolation.

Types[edit]

There are three main types of PPA: semantic variant PPA, nonfluent/agrammatic variant PPA, and logopenic variant PPA. Each type has distinct symptoms and is associated with different patterns of brain atrophy.

Causes[edit]

The exact cause of PPA is unknown, but it is thought to be related to the accumulation of abnormal proteins in the brain. These proteins can damage nerve cells in the areas of the brain that control language.

Diagnosis[edit]

Diagnosis of PPA is based on a detailed clinical evaluation, including a thorough medical history, neurological examination, and cognitive testing. Imaging studies such as MRI or PET scan may also be used to identify patterns of brain atrophy.

Treatment[edit]

There is currently no cure for PPA, but treatment can help manage symptoms. This may include speech and language therapy, medications to manage symptoms, and supportive care to help individuals and their families cope with the challenges of the disease.

Prognosis[edit]

The progression of PPA is typically slow, with language skills gradually declining over a period of years. However, the disease can eventually affect other cognitive abilities and lead to a more generalized form of dementia.

See also[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.